Cargando…

De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia

Febrile neutropenia (FN) is a common serious complication in patients undergoing hematopoietic stem cell transplantation (HSCT) requiring urgent evaluation and initiation of empiric broad spectrum antibiotics (BSA). The appropriate duration of BSA for FN in patients with negative cultures and no ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rearigh, Lindsey, Stohs, Erica, Freifeld, Alison, Zimmer, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340662/ https://www.ncbi.nlm.nih.gov/pubmed/32556455 http://dx.doi.org/10.1007/s00277-020-04132-0

Ejemplares similares

2666. De-escalation of Broad-Spectrum Antibiotics in Hematopoietic Stem Cell Transplant Patients During Initial Episode of Febrile Neutropenia
por: Rearigh, Lindsey, et al.
Publicado: (2019)

2688. The Clinical Impact of Early De-escalation of Broad-Spectrum Antibiotics in Acute Myeloid Leukemia Patients with Febrile Neutropenia
por: Davis, Matthew, et al.
Publicado: (2019)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Comparison of Empiric Antibiotic Escalation Therapy with Vancomycin (VAN) versus Linezolid (LIN) in Patients with Febrile Neutropenia
por: Mayer, Karin, et al.
Publicado: (2022)

Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
por: Giurici, Nagua, et al.
Publicado: (2011)

253. Febrile Neutropenia Antibiotic De-escalation Study in Acute Myeloid Leukemia Patients With Prolonged Neutropenia
por: Alegria, William, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
por: Zimmer, Andrea J, et al.
Publicado: (2022)

P1554: SYSTEMATIC REVIEW OF EXTENDED VERSUS BOLUS INFUSION OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS FOR FEBRILE NEUTROPENIA
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

574. De-escalation of Broad Spectrum Antibiotics during Cytokine Release Syndrome with Haploidentical Hematopoietic Stem Cell Transplantation
por: Schiffer, Molly, et al.
Publicado: (2020)

Effectiveness of Extended or Continuous vs. Bolus Infusion of Broad-Spectrum Beta-Lactam Antibiotics for Febrile Neutropenia: A Systematic Review and Meta-Analysis
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Less empiric broad-spectrum antibiotics is more in the ICU
por: da Fonseca Pestana Ribeiro, Jose Mauro, et al.
Publicado: (2019)

Safety and Efficacy of Antibiotic De-escalation and Discontinuation in High-Risk Hematological Patients With Febrile Neutropenia: A Single-Center Experience
por: Verlinden, Anke, et al.
Publicado: (2021)

Time to antibiotics and outcomes in cancer patients with febrile neutropenia
por: Perron, Thomas, et al.
Publicado: (2014)

Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Masetti, Riccardo, et al.
Publicado: (2022)

Utility of Urine Cultures During Febrile Neutropenia Workup in Hematopoietic Stem Cell Transplantation Recipients Without Urinary Symptoms
por: Tran, Mya, et al.
Publicado: (2023)

1594. Evaluating Clinical Outcomes of an Alternative Cefepime Dosing Regimen as Empiric Antibiotic Therapy in Hospitalized Adults with Febrile Neutropenia
por: Haiduc, Manuela, et al.
Publicado: (2018)

The Value of Metagenomic Next-Generation Sequencing in Hematological Malignancy Patients with Febrile Neutropenia After Empiric Antibiotic Treatment Failure
por: Zhang, Meng, et al.
Publicado: (2022)

Impact of an alternating first-line antibiotics strategy in febrile neutropenia
por: Tan, Ban Hock, et al.
Publicado: (2018)

De-escalation of Broad Spectrum Antibiotics Following Negative Cultures in Pneumonia: Rates and Outcomes
por: Deshpande, Abhishek, et al.
Publicado: (2017)

Rare severe mycotic infections in children receiving empirical caspofungin treatment for febrile neutropenia
por: Yilmaz Karapinar, Deniz, et al.
Publicado: (2015)

Bacterial Spectrum and Antimicrobial Resistance Pattern in Cancer Patients with Febrile Neutropenia
por: Vahedian-Ardakani, Hassan Ali, et al.
Publicado: (2019)

Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department
por: Peyrony, Olivier, et al.
Publicado: (2020)

Antimicrobial de-escalation in patients with high-risk febrile neutropenia: Attitudes and practices of adult hospital care providers
por: Gorsline, Chelsea A., et al.
Publicado: (2021)

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia
por: Yalçın, Cumali, et al.
Publicado: (2022)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Quality Initiative to Improve time to Antibiotics for Febrile Pediatric Patients with Potential Neutropenia
por: Monroe, Kathy, et al.
Publicado: (2018)

Broad-Spectrum Antibiotic Use at Choice, Change, and Completion Throughout VA: Patterns of Initiation and De-escalation
por: Goetz, Matthew, et al.
Publicado: (2017)

Continuation Versus De-escalation of Broad-Spectrum Antibiotic Therapy in Critically Ill COVID-19 Patients
por: Aldardeer, Namareq F., et al.
Publicado: (2023)

1585. Bloodstream Infection Survey in High-Risk Oncology Patients (BISHOP) with Fever and Neutropenia (FN): Correlation Between Initial Empiric Antibiotic Regimen Correlation and Susceptibility Patterns
por: Zimmer, Andrea, et al.
Publicado: (2018)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_baqbliav98q6rekj2kq598j61d